Containment-Verification Testing For Pharmaceutical Equipment Performance - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Containment-Verification Testing For Pharmaceutical Equipment Performance
A Good Practice Guide from the International Society of Pharmaceutical Engineering provides a framework to assess how well pharmaceutical equipment contains hazardous APIs.


Pharmaceutical Technology
Volume 37, Issue 5, pp. s24-s27

Conclusion

Containment-verification testing of equipment and containment systems is an accepted means for evaluating the containment capability of containment systems and processing equipment in the pharmaceutical and biotechnology industries under defined conditions. ISPE’s Good Practice Guide: Assessing the Particulate Containment Performance of Pharmaceutical Equipment describes the methodologies for performing containment verification testing for both FAT and SAT scenarios. The guide specifies a methodology using a surrogate material to verify containment performance by setting a CPT and then performing air and surface sampling as outlined in standard protocols for containment systems. By following the guidelines, users can generate accurate and repeatable data to perform statistical analysis and confirm that airborne-release concentrations will not normally exceed the CPT. >

References>

1. B.D. Naumann and E.V. Sargent, “Setting Occupational Exposure Limits for Pharmaceuticals,” Occup. Med. , 12(1): 67-79 (1997). >

2. OSHA, Sec. II: Ch. 1, “Personal Sampling for Air Contaminants,” in OSHA Technical Manual (OTM) (Washington, DC, June 24, 2008). >

3. OSHA, Sec. II: Ch. 2, “Occupational Skin Exposure V. Wipe Sampling Methodology,” OSHA Technical Manual (OTM) , (Washington, DC, June 24, 2008). >

4. ISPE, Good Practice Guide: Assessing the Particulate Containment Performance of Pharmaceutical Equipment (Second Edition, Tampa, FL, 2012) >

All figures and tables courtesy of the International Society of Pharmaceutical Engineering.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology,
Click here